MAC Clinical Research
MAC Clinical Research is a full-service, global contract research organisation (CRO) headquartered in the UK, operating a fully owned network of dedicated research sites.
Last updated September 16, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
MAC Clinical Research is a full-service, flexible, global Contract Research Organisation (CRO) with headquarters in the UK. It owns a network of Dedicated Research Sites and also has offices within the EU and the US. Its service areas include Phase 1 clinical trials, biometrics, laboratory services (bioanalytical and pathology), pharmaceutical services including GMP manufacturing, a sleep laboratory, and patient engagement through MAC EnVision®. The company states it has built a fully owned network of clinical sites over the last 30 years.
History
MAC Clinical Research describes itself as a full-service, global pharmaceutical contract research organisation (CRO) that has built a fully owned network of clinical sites over the last 30 years. Its published history timeline records milestones including: 2008 (patient enrolment, recruitment and retention centre established); 2009 (CliniSafe wins SCRIP award for Best Technological Award in Clinical Trials); 2010 (CliniSafe wins SCRIP award); 2011 (Queen's Award; research facility opens in the Midlands; Institute of Directors North West Director of the Year Awards — Mark Dale wins award for Business Innovation); 2013 (Pharmacy Department opens first aseptic services suite in Manchester); 2014 (Pharmacy Department opens aseptic services suite in Leeds; Memory Assessment and Research Centre opens in Leeds); 2015 (wins Health and Care Business of The Year at the Red Rose Awards 2015; Neuroscience Centre of Excellence opens at Citylabs 1.0 in Manchester); 2016 (Dedicated Research Centre opens in Barnsley; GMP Pharmaceutical Manufacturing facilities open in Leeds; Dedicated Research Centre opens in Liverpool; Manchester Phase 1 Unit receives MHRA Phase 1 Accreditation; CEO Dr Mark Dale awarded Honorary Membership of the Faculty of Pharmaceutical Medicine); 2017 (Dedicated Research Centre opens in Stockton on Teesside; Biometrics services commence); 2018 (Sleep Laboratory opens at Liverpool Clinic); 2020 (Contract Research Services: a full-service CRO); 2021 (MAC Incorporated in Ireland; first USA office opens in Philadelphia; Pharmacovigilance Services); 2023 (MAC Incorporated in Australia; MAC Incorporated in Pakistan); 2024 (Dedicated Research Centre opens in Glasgow following MAC's acquisition of Intelligent Clinical).
Products and positioning
Full-service, flexible, global Contract Research Organisation with a fully owned network of dedicated research sites.
Product categories. Phase I clinical trials · Biometrics solutions · Bioanalytical and pathology laboratory services · GMP pharmaceutical manufacturing · Sleep laboratory / polysomnography · Patient engagement (MAC EnVision®)
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/mac-clinical-research-united-kingdom · Editorial policy · How profiles are compiled